Without the benefit of examination and testing, coloplast is precluded from commenting on the condition of the device or the cause of the occurrence.Should additional facts prompt us to alter or supplement any information or conclusions contained in the original mdr or in any prior supplemental reports, a follow-up report will be submitted.Coloplast has not been provided any corroborating evidence to verify the information contained in this report.
|
As reported to coloplast, though not verified, llq abdominal pain, yeast infections x 3 since 11/2010, pelvic pain, extrusion /infection of supris/coloplast, periurethral fibrosis, recurrent utis, vaginal pain/ bleeding.On (b)(6) 2020: complete excision of supris/coloplast, urethrolysis, resection/closure of disrupted vaginal/suburethral mucosa, cystoscopy.Intraoperative findings: disruption of supris/coloplast incision with extrusion of supris/coloplast, purulent/malodorous material noted along the course of the sling extending bilaterally to supris/coloplast margins (cultured), suburethral fibrosis that required urethrolysis.No other adverse patient effects were reported.
|